Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies https://www.nature.com/articles/s41409-024-02311-5
Discover the world at Altruu, The Discovery Engine
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies https://www.nature.com/articles/s41409-024-02311-5